ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,484.81
      0.21%
      US Tech 100
      19,403.20
      0.00%
      Dow Jones
      38,813.76
      0.09%
      Brent Oil
      84.715
      0.97%
      Bitcoin
      64,382.64
      -3.17%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. I MAB (IMAB)

      7. I MAB (IMAB) News

      IMAB

      I MAB (IMAB)

      I MAB
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IMAB
      DateTimeSourceHeadlineSymbolCompany
      06/06/20247:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
      06/06/20247:00AMPR Newswire (US)I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical OfficerNASDAQ:IMABI MAB
      06/05/20247:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
      06/05/20247:00AMPR Newswire (US)I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersNASDAQ:IMABI MAB
      05/30/20245:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
      05/23/20245:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
      05/23/20245:05PMGlobeNewswire Inc.I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024NASDAQ:IMABI MAB
      05/22/20247:00AMPR Newswire (US)I-Mab to Participate at the Jefferies Global Healthcare ConferenceNASDAQ:IMABI MAB
      04/30/20247:00AMPR Newswire (US)I-MAB Filed 2023 Annual Report on Form 20-FNASDAQ:IMABI MAB
      04/05/20247:00AMPR Newswire (US)I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:IMABI MAB
      04/02/20244:01PMPR Newswire (US)I-Mab Announces Closing of the Divestiture of Business Operations in ChinaNASDAQ:IMABI MAB
      03/14/20245:00PMPR Newswire (US)I-Mab Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:IMABI MAB
      02/09/20244:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMABI MAB
      02/08/20246:07AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
      02/07/20246:52AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
      02/07/20246:00AMPR Newswire (US)I-Mab Signs Agreement to Divest its Assets and Business Operations in ChinaNASDAQ:IMABI MAB
      02/06/20248:55PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IMABI MAB
      02/06/20246:34AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
      01/05/20246:21AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
      01/02/20245:08PMDow Jones NewsADRs Slump; FLJ Group Declines 21%NASDAQ:IMABI MAB
      12/29/20236:12AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
      12/26/20236:22AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
      12/01/20232:41PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IMABI MAB
      11/16/20236:43AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
      11/06/20238:00AMPR Newswire (US)I-Mab Announces Participation at Jefferies and Piper Conferences in NovemberNASDAQ:IMABI MAB
      11/02/20238:00AMPR Newswire (US)Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)NASDAQ:IMABI MAB
      11/01/20238:00AMPR Newswire (US)I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023NASDAQ:IMABI MAB
      10/16/20238:00AMPR Newswire (US)I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023NASDAQ:IMABI MAB
      10/10/202311:04AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
      10/10/20238:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
       Showing the most relevant articles for your search:NASDAQ:IMAB